Sarcopenia and Inflammation

Sarcopenia and Inflammation - SAINT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023509

Enrollment

Registered

2020-11-04

Start date

2020-11-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M62.50

Interventions

Group 1: All patients who are intended for an allogeneic stem cell transplant at the University Clinic in Ulm are screened for sarcopenia as part of the preliminary examinations. 40 consecutive patien

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Scheduled for allogenic stem cell transplantation

Exclusion criteria

Exclusion criteria: no consent

Design outcomes

Primary

Measure	Time frame
Overall mortality	—

Secondary

Measure	Time frame
Development of sarcopenia	—

Countries

Germany

Contacts

Public ContactJohannes Kirsten

Sektion Sport- und Rehabilitationsmedizin Universität Ulm

johannes.kirsten@uni-ulm.de+49-731-500-45350

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026